By Pete Brush ( November 15, 2017, 6:31 PM EST) -- Former Katten Muchin Rosenman LLP attorney Evan Greebel warned a former Retrophin Inc. executive that a move to convert a $900,000 Martin Shkreli investment in the drug developer to a loan was a possible "showstopper" that outside investors had to hear about, a jury weighing conspiracy charges against Greebel heard Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.